Earnings Feed
Start Free
Home/Filings/4/0000950170-24-084290
4//SEC Filing

HAMILTON CHRISTINE E 4

Accession 0000950170-24-084290

CIK 0001833214other
View on SEC.govCompany Profile

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 4:30 PM ET

Size

14.9 KB

Accession

0000950170-24-084290

Insider Transaction Report

Form 4
Period: 2024-07-15
SAB Biotherapeutics, Inc.SABS
HAMILTON CHRISTINE E
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2024-07-15+20,000→ 20,000 total
    Exercise: $2.90Exp: 2034-07-15→ Common Stock (20,000 underlying)
  • Award

    Stock Option (right to buy)

    2024-07-15+4,447→ 4,447 total
    Exercise: $2.90Exp: 2034-07-15→ Common Stock (4,447 underlying)
  • Award

    Stock Option (right to buy)

    2024-07-15+44,202→ 44,202 total(indirect: By Spouse)
    Exercise: $5.40Exp: 2024-07-15→ Common Stock (44,202 underlying)
  • Award

    Stock Option (right to buy)

    2024-07-15+2,326→ 2,326 total(indirect: By Spouse)
    Exercise: $2.90Exp: 2034-07-15→ Common Stock (2,326 underlying)
  • Award

    Stock Option (right to buy)

    2024-07-15+5,815→ 5,815 total
    Exercise: $5.40Exp: 2034-07-15→ Common Stock (5,815 underlying)
Footnotes (6)
  • [F1]Represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer (the "Board"). Shares underlying the option vest in two equal annual installments on July 15, 2025, and 2026.
  • [F2]Represents a one-time grant to the Reporting Person as a member of the Board. Shares underlying the option are fully vested.
  • [F3]Represents a one-time grant to the Reporting Person as a member of the Board. Shares underlying the option vest in three equal annual installments on July 15, 2025, 2026, and 2027.
  • [F4]Represents a one-time grant to the Reporting Person's spouse as an advisor to the Board. Shares underlying the option are fully vested.
  • [F5]Represents a one-time grant to the Reporting Person's spouse as an advisor to the Board. Shares underlying the option vest in three equal annual installments on July 15, 2025, 2026, and 2027.
  • [F6]This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.

Documents

1 file

Issuer

SAB Biotherapeutics, Inc.

CIK 0001833214

→
Entity typeother

Related Parties

1
  • filerCIK 0001216114

Filing Metadata

Form type
4
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 4:30 PM ET
Size
14.9 KB
View on SEC.gov